BRIEF REPORT

Fig. 1. Clinical and histopathologic features of squamous cell carcinoma (SCC). (A) Erythematous crusted plaque on the right temple.
(B, C) Skin biopsy specimen with serous crust and atypical keratinocytes invading the dermis, which led to the diagnosis of invasive SCC (H&E: B, original magnification; C, ×200). We received the patient's consent form about publishing all photographic materials. Dear Editor: Surgical excision is the main treatment of cutaneous squamous cell carcinoma (SCC). However, owing to its high incidence in older age groups, some patients may not be suitable for surgery. We report a rare case of invasive SCC treated with methyl aminolevulinic acid photodynamic therapy (MAL-PDT) with ablative CO2 fractional laser. An 83-year-old female presented with a 2-year history of an asymptomatic erythematous crusted plaque on the right temple (Fig. 1A) . She had undergone laser therapy once, without a successful outcome. Skin biopsy revealed atypical keratinocytes invading the dermis. The keratinocytes were pleomorphic and hyperchromatic with atypical mitotic figures (Fig. 1B, C) . The patient refused to undergo surgery and radiotherapy; thus, she was treated with MAL-PDT with ablative CO2 fractional laser 3 times, with a 630-nm light-emitting diode at a light dose of 37 J/cm 2 .
A Case of Squamous
Ablative CO2 fractional laser (eCO2; Lutronic Inc., Seoul, Korea) was performed with 1,000 μm beam size, 30 W peak power, 60 mJ pulse energy, and 100% total density. Immediately after ablative CO2 fractional laser, we applied MAL to the lesion and covered it with occlusive dressing for 2 hours, after which PDT was performed. The second and third sessions were conducted 3 and 7 weeks later, respectively. Two months after the last treatment, a brownish patch remained on the treated area; however, no residual tumor was seen on the skin biopsy (Fig. 2) . Two years after the last treatment, we found that there was no recurrence. Generally, owing to limitations in the ability to treat deepset disease with local treatment, PDT alone is not recommended for SCC lesions with a potential for regional spread 1 . PDT has reduced efficacy for microinvasive and nodular invasive SCC, for which 24-month clearance rates of 57% and 26%, respectively, have been reported 2 . In a systematic review article, after an apparently successful initial response of SCCs to PDT, pooled average recurrence of 26.4% (12.3% to 43.7%; 8 studies) was significantly higher than other treatments 3 .
PDT with ablative CO2 fractional laser is more efficacious than conventional MAL-PDT for treating microinvasive SCC lesions 4 . We report a rare case of invasive SCC treated with MAL-PDT with ablative CO2 fractional laser, without recurrence for 24 months after the last treatment. Ablative fractional laser facilitates the delivery and uptake of topical MAL deep into the skin, enhancing porphyrin synthesis and photodynamic activation 5 . The ablation fraction laser was used intentionally to drill tiny holes, so the tumor mass debulking effect seems to be minimal. In the case of SCC, PDT with ablative CO2 fractional laser may be particularly useful because of the deep invasion of the lesion. Among patients with SCC who are not suitable for surgery or radiotherapy, MAL-PDT with ablative CO2 fractional laser might be another noninvasive treatment option. However, this type of treatment should be carefully decided and close follow up is necessary after treatment as SCC is a disease that can progress to metastasis.
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